SkyWater, NanoDx to develop nanoscale sensors for Covid-19 testing


The deal facilitates the technology transfer for qualification and production ramp of nanoscale sensors to improve rapid testing for various indications

Semiconductor manufacturer SkyWater Technology has partnered with medical device firm NanoDx to develop and produce nanoscale sensors for rapid Covid-19 testing and other vital diagnostics. The deal facilitates the technology transfer for qualification and production ramp of nanoscale sensors to improve precise, rapid testing for various indications such as Covid-19, traumatic brain injury, sepsis and stroke.

By partnering with SkyWate, NanoDx intends to scale the product as well as pursue an emergency use authorisation (FDA) from the US Food and Drug Administration  for rapid, two-minute, point-of-care Covid-19 testing.

The company has recently entered into a licencing agreement with IBM Research to boost its efforts to launch an array of diagnostic solutions into the market.

Read the article on nsmedicaldevices.com: https://www.nsmedicaldevices.com/news/skywater-nanodx-nanoscale-sensors-covid-19/

 

Return to Industry News Page